American Vietnamese Biotech Incorporation Share Price

Equities

AMV

VN000000AMV5

Pharmaceuticals

End-of-day quote HANOI S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
3,100 VND -3.13% Intraday chart for American Vietnamese Biotech Incorporation 0.00% -20.51%

Financials

Sales 2018 451B 17.58M 1.48B Sales 2019 487B 19.01M 1.6B Capitalization 930B 36.27M 3.06B
Net income 2018 215B 8.39M 708M Net income 2019 220B 8.57M 724M EV / Sales 2018 2.11 x
Net cash position 2018 77.23B 3.01M 254M Net Debt 2019 37.4B 1.46M 123M EV / Sales 2019 1.99 x
P/E ratio 2018
4.79 x
P/E ratio 2019
4.23 x
Employees -
Yield 2018 *
-
Yield 2019
11.4%
Free-Float 74.48%
More Fundamentals * Assessed data
Dynamic Chart
American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
An unknown buyer entered into an agreement to acquire Bac Lieu High Techcare Clinic Joint Stock Company from American Vietnamese Biotech Incorporation for VND 29.4 billion. CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
An unknown buyer acquired a 5.27% stake in American Vietnamese Biotech Incorporation (HNX : AMV) from Nguyen Thi Hien. CI
American Vietnamese Biotech Incorporation agreed to acquire 75% stake in Leopard Solutions Joint Stock Company for VND 6000 million. CI
American Vietnamese Biotech Incorporation announced that it has received VND 379.62045 billion in funding from Lotus Investment Management Joint Stock Company and other investors CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day-3.13%
Current month-18.42%
1 month-22.50%
3 months-20.51%
6 months-16.22%
Current year-20.51%
More quotes
1 week
3 100.00
Extreme 3100
3 300.00
1 month
3 000.00
Extreme 3000
4 000.00
Current year
3 000.00
Extreme 3000
4 300.00
1 year
3 000.00
Extreme 3000
5 700.00
3 years
2 500.00
Extreme 2500
15 800.00
5 years
2 500.00
Extreme 2500
18 428.57
10 years
1 428.57
Extreme 1428.5714
20 204.08
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 -
Chief Tech/Sci/R&D Officer - -
Comptroller/Controller/Auditor - 18/20/18
Members of the board TitleAgeSince
Chief Executive Officer 68 -
Chairman 60 29/18/29
Director/Board Member - 30/20/30
More insiders
Date Price Change Volume
26/24/26 3,100 -3.12% 821,031
25/24/25 3,200 -3.03% 343,566
24/24/24 3,300 +6.45% 721,619
23/24/23 3,100 -3.12% 415,656
22/24/22 3,200 +3.23% 730,632

End-of-day quote HANOI S.E., April 26, 2024

More quotes
American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.
More about the company